p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α–mediated down-regulation of CXCL12Kensuke Kojima, Michael Andreeff, Teresa McQueen et al.|Blood|2011Cited by 105
Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114CKazuhiko Mishima, Haruhiko Fukuda, Ryo Nishikawa et al.|Neuro-Oncology|2022Cited by 29
Diffusely infiltrating glioma with CREBBP–BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case reportAyako Yamazaki, Sumihito Nobusawa, Yasuhito Arai et al.|Brain Tumor Pathology|2022Cited by 13
Randomized phase III study of high-dose methotrexate and whole brain radiotherapy with or without concomitant and adjuvant temozolomide in patients with newly diagnosed primary central nervous system lymphoma: JCOG1114C.Kazuhiko Mishima, Haruhiko Fukuda, Ryo Nishikawa et al.|Journal of Clinical Oncology|2020Cited by 9